Harrow Health Inc.
News
Harrow to Present at Three Investor Conferences in September in New York
Business Wire Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences in September in New York...\n more…
HROW Stock Earnings: Harrow Beats EPS, Misses Revenue for Q2 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nHROW stock results show that Harrow beat analyst estimates for earnings per share but missed on revenue for the second quarter of...\n more…
Harrow Announces Second Quarter 2024 Financial Results
Business Wire Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the second quarter and six months ended June 30, 2024. The Company also posted its second quarter...\n more…
Harrow To Report Second Quarter 2024 Financial Results After Market Close on August 7, 2024
Business Wire Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will report its financial results for the second quarter ended June 30, 2024, on Wednesday, August 7...\n more…
Harrow Health (HROW) Gets a Buy from Craig-Hallum
TipRanks Financial Blog Craig-Hallum analyst Chase Knickerbocker assigned a Buy rating to the stock today. The company's shares closed last Friday at $23.61. According to ...\n more…
Harrow to Attend 2024 ASRS Annual Meeting
Business Wire Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that its management team would attend the 2024 American Society of Retina Specialists (ASRS) Annual...\n more…